Page last updated: 2024-08-21

malondialdehyde and id-6105

malondialdehyde has been researched along with id-6105 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hong, YS; Kim, TY; Lee, HS; Lee, JJ; Ryu, JS; Sohn, UD	1

Other Studies

1 other study(ies) available for malondialdehyde and id-6105

Article	Year
In vivo antitumor efficacy and cardiotoxicity of novel anthracycline ID6105 (11-hydroxy-aclacinomycin X, Hyrubicin). Cancer chemotherapy and pharmacology, 2006, Volume: 57, Issue:6 Topics: Aclarubicin; Animals; Antineoplastic Agents; Cell Line, Tumor; Doxorubicin; Female; Heart; Humans; Male; Malondialdehyde; Mice; Mice, Inbred BALB C; Myocardium; Nucleic Acid Synthesis Inhibitors; Rats; Rats, Sprague-Dawley; Topoisomerase II Inhibitors; Tumor Burden; Xenograft Model Antitumor Assays	2006

Article

Year

In vivo antitumor efficacy and cardiotoxicity of novel anthracycline ID6105 (11-hydroxy-aclacinomycin X, Hyrubicin).

Cancer chemotherapy and pharmacology, 2006, Volume: 57, Issue:6

Topics: Aclarubicin; Animals; Antineoplastic Agents; Cell Line, Tumor; Doxorubicin; Female; Heart; Humans; Male; Malondialdehyde; Mice; Mice, Inbred BALB C; Myocardium; Nucleic Acid Synthesis Inhibitors; Rats; Rats, Sprague-Dawley; Topoisomerase II Inhibitors; Tumor Burden; Xenograft Model Antitumor Assays

2006